Seroatlas · Human Serome Atlas

PGM1

Phosphoglucomutase-1

Also known as: PGM1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P36871
Gene
PGM1
Ensembl
ENSG00000079739
Chromosome
1
Canonical length
562 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Cytosol

OverviewNCBI Gene

The protein encoded by this gene is an isozyme of phosphoglucomutase (PGM) and belongs to the phosphohexose mutase family. There are several PGM isozymes, which are encoded by different genes and catalyze the transfer of phosphate between the 1 and 6 positions of glucose. In most cell types, this PGM isozyme is predominant, representing about 90% of total PGM activity. In red cells, PGM2 is a major isozyme. This gene is highly polymorphic. Mutations in this gene cause glycogen storage disease type 14. Alternativley spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Mar 2010]

Canonical amino-acid sequenceUniProt

562 residues, UniProt reviewed canonical sequence.

>P36871|PGM1
     1  MVKIVTVKTQ AYQDQKPGTS GLRKRVKVFQ SSANYAENFI QSIISTVEPA QRQEATLVVG
    61  GDGRFYMKEA IQLIARIAAA NGIGRLVIGQ NGILSTPAVS CIIRKIKAIG GIILTASHNP
   121  GGPNGDFGIK FNISNGGPAP EAITDKIFQI SKTIEEYAVC PDLKVDLGVL GKQQFDLENK
   181  FKPFTVEIVD SVEAYATMLR SIFDFSALKE LLSGPNRLKI RIDAMHGVVG PYVKKILCEE
   241  LGAPANSAVN CVPLEDFGGH HPDPNLTYAA DLVETMKSGE HDFGAAFDGD GDRNMILGKH
   301  GFFVNPSDSV AVIAANIFSI PYFQQTGVRG FARSMPTSGA LDRVASATKI ALYETPTGWK
   361  FFGNLMDASK LSLCGEESFG TGSDHIREKD GLWAVLAWLS ILATRKQSVE DILKDHWQKY
   421  GRNFFTRYDY EEVEAEGANK MMKDLEALMF DRSFVGKQFS ANDKVYTVEK ADNFEYSDPV
   481  DGSISRNQGL RLIFTDGSRI VFRLSGTGSA GATIRLYIDS YEKDVAKINQ DPQVMLAPLI
   541  SIALKVSQLQ ERTGRTAPTV IT

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PGM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.2
Highest tissue expression
1,461 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 1,461 nTPM
  • tongue: 736 nTPM
  • liver: 262 nTPM
  • heart muscle: 174 nTPM
  • pancreas: 112 nTPM
  • adipose tissue: 107 nTPM

Single-cell type

  • myonuclei: 368 nCPM
  • hepatocytes: 306 nCPM
  • extravillous trophoblasts: 301 nCPM
  • breast lactating cells: 250 nCPM
  • thymic myoid cells: 226 nCPM
  • granulosa cells: 219 nCPM

Immune cell

  • eosinophil: 49 nTPM
  • myeloid DC: 48 nTPM
  • basophil: 46 nTPM
  • NK-cell: 44 nTPM
  • gdT-cell: 41 nTPM
  • neutrophil: 39 nTPM

Brain region

  • choroid plexus: 81 nTPM
  • medulla oblongata: 63 nTPM
  • thalamus: 47 nTPM
  • midbrain: 42 nTPM
  • basal ganglia: 41 nTPM
  • cerebellum: 41 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about PGM1.

Disease | AllUniProt

Conditions PGM1 is implicated in, by any mechanism.

Disease | GeneticClinVar

45 pathogenic / likely-pathogenic of 531 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.32
gnomAD pLI
0
gnomAD missense Z
-0.23
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PGM1 as an antibody target. Whether an autoantibody or antibody against PGM1 could matter depends on whether native PGM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PGM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label PGM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PGM1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...